Congruence Therapeutics

Home - Congruence

Montreal, Canada · Founded 2019 · $137.0M raised

Headquarters
Montreal
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$137.0M
Last Round
$40.0M Series BMar 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Congruence Therapeutics is a Montreal-based drug discovery company harnessing protein dynamics, biophysics, machine learning, and computational chemistry to design small-molecule correctors for diseases caused by protein misfolding. Its proprietary Revenir platform models the full conformational ensemble of target proteins.

Summary

Congruence Therapeutics is a Biotech company based in Montreal, Canada, founded in 2019. It has raised $137.0M in total across 4 rounds, most recently a $40.0M Series B round in Mar 2026. Investors include Lumira Ventures, Amplitude Ventures and Fonds de solidarité FTQ.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMar 2026
$40.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Congruence Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/congruence-therapeutics"><img src="https://indexed.vc/api/badge/company/congruence-therapeutics" alt="Congruence Therapeutics on Indexed.vc" width="260" height="76" /></a>